These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18307245)

  • 41. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered directional connectivity in Parkinson's disease during performance of a visually guided task.
    Tropini G; Chiang J; Wang ZJ; Ty E; McKeown MJ
    Neuroimage; 2011 Jun; 56(4):2144-56. PubMed ID: 21402160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Speech production in Parkinson's disease: I. An electropalatographic investigation of tongue-palate contact patterns.
    McAuliffe MJ; Ward EC; Murdoch BE
    Clin Linguist Phon; 2006; 20(1):1-18. PubMed ID: 16393795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loudness perception and speech intensity control in Parkinson's disease.
    Clark JP; Adams SG; Dykstra AD; Moodie S; Jog M
    J Commun Disord; 2014; 51():1-12. PubMed ID: 25194745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Task-based profile of vocal intensity decline in Parkinson's disease.
    Rosen KM; Kent RD; Duffy JR
    Folia Phoniatr Logop; 2005; 57(1):28-37. PubMed ID: 15655339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Péron J; Grandjean D; Le Jeune F; Sauleau P; Haegelen C; Drapier D; Rouaud T; Drapier S; Vérin M
    Neuropsychologia; 2010 Mar; 48(4):1053-62. PubMed ID: 20005239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of a concurrent task on Parkinsonian speech.
    Ho AK; Iansek R; Bradshaw JL
    J Clin Exp Neuropsychol; 2002 Feb; 24(1):36-47. PubMed ID: 11935422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glottographic measures before and after levodopa treatment in Parkinson's disease.
    Jiang J; Lin E; Wang J; Hanson DG
    Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Facial expression decoding in early Parkinson's disease.
    Pell MD; Leonard CL
    Brain Res Cogn Brain Res; 2005 May; 23(2-3):327-40. PubMed ID: 15820640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.
    Goberman A; Coelho C; Robb M
    J Commun Disord; 2002; 35(3):217-39. PubMed ID: 12064785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes of rhythm of vocal fundamental frequency in sensorineural hearing loss and in Parkinson's disease.
    Lee GS; Lin SH
    Chin J Physiol; 2009 Dec; 52(6):446-50. PubMed ID: 20337153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External cueing facilitates auditory-motor integration for speech control in individuals with Parkinson's disease.
    Huang X; Fan H; Li J; Jones JA; Wang EQ; Chen L; Chen X; Liu H
    Neurobiol Aging; 2019 Apr; 76():96-105. PubMed ID: 30710834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Methodology to Differentiate Parkinson's Disease and Aging Speech Based on Glottal Flow Acoustic Analysis.
    Gómez-Rodellar A; Palacios-Alonso D; Ferrández Vicente JM; Mekyska J; Álvarez-Marquina A; Gómez-Vilda P
    Int J Neural Syst; 2020 Oct; 30(10):2050058. PubMed ID: 32880202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.